This study compared vitamin D 25(OH)D plasma levels with different health related scores, inflammatory markers, markers of cellular damage and coagulation and lung radiological findings during COVID-19 illness. Patients with low 25(OH)D...
This retrospective cohort study evaluated the role of serum vitamin D levels in severe disease outcomes among COVID-19 patients in Detroit, MI and found no association of vitamin D levels with mortality, the need for mechanical ventilation, ICU...
Vitamin D deficiency and obesity increases risk of testing positive for COVID-19.
In this retrospective cross-sectional study of 65 elderly patients serum, Vitamin D deficiency was associated with more severe lung involvement, longer disease duration, and risk of death in elderly COVID-19 patients.
Study participants were 137 patients who were admitted to a hospital in Rome Italy between March 1 and April 30, 2020 with COVID-19 who had serum 25(OH)D levels
A high, single oral dose of 200,000 IU vitamin D3, compared to placebo, did not significantly reduce hospital length of stay in moderately to severely ill hospitalized patients diagnosed with COVID-19 in Brazil during the study period of June-August 2020.
This study did not find a benefit associated with vitamin D supplementation in COVID-19 patients but did identify that vitamin D deficiency may be a risk factor for higher in-patient mortality.
This study suggests that there is a potential association between vitamin D deficiency on hospital admission and mortality of COVID-19 pneumonia, independent of other conditions that might be...
This population study found a relationship between vitamin D levels and the number of COVID-19 cases, but not deaths in Asia Pacific countries. While the study demonstrated a correlation...
This study of the COVID-19 epidemic and its effect on UK Biobank participants identified vitamin D, age, male sex, and Black ethnicity as key explanatory factors for COVID-19 death. However, once an adjustment for multiple risk...
